Market Overview:
The global thyroid disorder market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of thyroid disorders, rising awareness about thyroid disorders, and technological advancements in the field of diagnosis and treatment of thyroid disorders. However, the high cost associated with diagnosis and treatment of thyroid disorders is expected to restrain the growth of this market during the forecast period. The global Thyroid Disorder Market is segmented on the basis type, application and region. On the basis type, it is segmented into hypothyroidism and hyperthyroidism. On application basis it is segmented into hospitals clinics others). Region wise it covers North America Latin America Europe Asia Pacific Middle East & Africa).
Product Definition:
A thyroid disorder is a medical condition that affects the function of the thyroid gland. The thyroid gland is located in the front of your neck and produces hormones that help regulate your body's energy levels and metabolism. There are many different types of thyroid disorders, including hyperthyroidism, hypothyroidism, goiter, and nodules. Thyroid disorders can cause a wide variety of symptoms such as weight gain or loss, hair loss or thinning hair, fatigue, mood swings, and changes in heart rate. They can also affect overall health and well-being.
Hypothyroidism:
Hypothyroidism is a condition where the thyroid gland does not produce enough hormones. This disorder is caused due to various reasons such as autoimmune disease, radioactive iodine treatment, viral infection or any other reason. The most common symptom of hypothyroidism in women is fatigue whereas men may have difficulty in gaining weight and experiencing erectile dysfunction.
Hypothyroidism market by Geographical Region: North America (U.S.
Hyperthyroidism:
Hyperthyroidism is a condition in which the thyroid gland produces an excessive amount of thyroid hormones. This excess production causes the symptoms of hyperthyroidism. The most common symptoms are increased sweating, rapid heartbeats, and feeling very warm (hyperthermia).
The exact cause of this disease is unknown; however, it has been found that there may be a genetic factor involved in some cases.
Application Insights:
Based on application, the global thyroid disorder market is segmented into hospitals, clinics and other medical facilities. The hospitals segment dominated the market in 2017 owing to factors such as high prevalence of patients suffering from thyroid disorders and availability of advanced healthcare services at hospital level. In addition, a large number of endocrinologists at hospital level who are skilled enough to diagnose and treat these disorders also play a significant role in driving this segment.
The clinics & other medical facilities application is expected to grow significantly over the forecast period due to increasing awareness about available treatment options among patients along with rising demand for diagnosis from family members or friends accompanying them for treatment. Furthermore, an increase in patient visits across various countries due to growing awareness about available treatments would further boost growth over the forecast period.
Regional Analysis:
North America dominated the global thyroid disorder market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness levels amongst individuals are some of the major factors responsible for this dominance. In addition, a high prevalence of autoimmune diseases such as Graves’ disease (hyperthyroidism) and Hashimoto’s thyroiditis (hypothyroidism) is also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in foreign direct investments by international companies into these economies has led to an increase in R&D activities which will further fuel regional demand during the estimated time span.
Growth Factors:
- Increasing prevalence of thyroid disorder
- Growing awareness about thyroid disorder
- Rising incidence of autoimmune diseases
- Technological advancements in the diagnosis and treatment of thyroid disorders
- increasing number of research studies on thyroid disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Thyroid Disorder Market Research Report
By Type
Hypothyroidism, Hyperthyroidism
By Application
Hospitals, Clinics, Others
By Companies
Pfizer Inc, Allergan, AbbVie Inc., Merck KGaA, RLC Labs, GlaxoSmithKline Plc, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Thyroid Disorder Market Report Segments:
The global Thyroid Disorder market is segmented on the basis of:
Types
Hypothyroidism, Hyperthyroidism
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc
- Allergan
- AbbVie Inc.
- Merck KGaA
- RLC Labs
- GlaxoSmithKline Plc
- Mylan
Highlights of The Thyroid Disorder Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hypothyroidism
- Hyperthyroidism
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thyroid Disorder Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thyroid disorder is a condition in which the thyroid gland does not produce enough hormones. This can lead to problems with your energy levels, weight, and mood. Thyroid disorder can also cause hair loss, fatigue, and difficulty concentrating.
Some of the key players operating in the thyroid disorder market are Pfizer Inc, Allergan, AbbVie Inc., Merck KGaA, RLC Labs, GlaxoSmithKline Plc, Mylan.
The thyroid disorder market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thyroid Disorder Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thyroid Disorder Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thyroid Disorder Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thyroid Disorder Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thyroid Disorder Market Size & Forecast, 2018-2028
4.5.1 Thyroid Disorder Market Size and Y-o-Y Growth
4.5.2 Thyroid Disorder Market Absolute $ Opportunity
Chapter 5 Global Thyroid Disorder Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thyroid Disorder Market Size Forecast by Type
5.2.1 Hypothyroidism
5.2.2 Hyperthyroidism
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thyroid Disorder Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thyroid Disorder Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thyroid Disorder Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thyroid Disorder Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thyroid Disorder Analysis and Forecast
9.1 Introduction
9.2 North America Thyroid Disorder Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thyroid Disorder Market Size Forecast by Type
9.6.1 Hypothyroidism
9.6.2 Hyperthyroidism
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thyroid Disorder Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thyroid Disorder Analysis and Forecast
10.1 Introduction
10.2 Europe Thyroid Disorder Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thyroid Disorder Market Size Forecast by Type
10.6.1 Hypothyroidism
10.6.2 Hyperthyroidism
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thyroid Disorder Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thyroid Disorder Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thyroid Disorder Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thyroid Disorder Market Size Forecast by Type
11.6.1 Hypothyroidism
11.6.2 Hyperthyroidism
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thyroid Disorder Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thyroid Disorder Analysis and Forecast
12.1 Introduction
12.2 Latin America Thyroid Disorder Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thyroid Disorder Market Size Forecast by Type
12.6.1 Hypothyroidism
12.6.2 Hyperthyroidism
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thyroid Disorder Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thyroid Disorder Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thyroid Disorder Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thyroid Disorder Market Size Forecast by Type
13.6.1 Hypothyroidism
13.6.2 Hyperthyroidism
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thyroid Disorder Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thyroid Disorder Market: Competitive Dashboard
14.2 Global Thyroid Disorder Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc
14.3.2 Allergan
14.3.3 AbbVie Inc.
14.3.4 Merck KGaA
14.3.5 RLC Labs
14.3.6 GlaxoSmithKline Plc
14.3.7 Mylan
